ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,480, issued on Sept. 9, was assigned to Freenome Holdings Inc. (San Francisco).
"Methods and systems for detecting colorectal cancer via nucleic acid methylation analysis" was invented by John St. John (Brisbane, Calif.), Steven Kothen-Hill (Millbrae, Calif.), Rui Yang (Burlingame, Calif.) and Adam Drake (Pacifica, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides methods and systems for screening or detecting a colorectal cancer or following colorectal disease progression that may be applied to cell-free nucleic acids such as cell-free DNA. The method may use detection of methylation signals within a single sequ...